Indivior Pharmaceuticals (INDV) Goodwill & Intangibles (2021 - 2026)

Indivior Pharmaceuticals' Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles fell 71.43% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 71.43% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, down 66.67% from the prior year.
• Goodwill & Intangibles steadied at $2.0 million in Q1 2026 per INDV's latest filing, from $2.0 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $70.0 million in Q4 2022 and bottomed at $2.0 million in Q1 2024.
• The 5-year median for Goodwill & Intangibles is $6.0 million (2024), against an average of $12.3 million.
• Across the five-year window, Goodwill & Intangibles sank 81.43% in 2023 and soared 250.0% in 2025, its largest moves.
• Year by year, Goodwill & Intangibles stood at $70.0 million in 2022, then sank by 81.43% to $13.0 million in 2023, then slumped by 53.85% to $6.0 million in 2024, then sank by 66.67% to $2.0 million in 2025, then changed by 0.0% to $2.0 million in 2026.
• Per Business Quant, the three latest INDV Goodwill & Intangibles figures stand at $2.0 million (Q1 2026), $2.0 million (Q4 2025), and $2.0 million (Q3 2025).